Company Overview
BioDiscovery develops and sells advanced software solutions and services
that enable its customers to revolutionize drug discovery and diagnostics by
efficiently managing, integrating, and analyzing data generated using
high-throughput microarray and CGH technology. BioDiscovery provides a full line of modular software packages spanning the
entire microarray process, including enterprise data management, image
processing, data mining, statistical analysis, and collaborative knowledge
management.
BioDiscovery was founded in 1997, in Los Angeles, California as a pioneer in
the nascent field of microarray informatics. The company has since positioned
itself as an innovative force in the industry with a strong intellectual
property portfolio encompassing six issued U.S. patents and significant number of
pending applications. This dedicated focus and these continued innovations have produced a
number of first-to-market products and technologies including:
- First commercial package for microarray analysis.
- First company to apply advanced spot image segmentation, and novel image analysis algorithms to microarray images.
- First company to promote and incorporate improved quantitative accuracy and the need for quality measures as well as statistical confidence measurements to microarrays.
- First fully automated image analysis product for microarrays.
- First array fabrication tracking and databasing tool.
- First company to implement Self-Organizing Maps (SOM) in a commercial product for analysis of expression array data.
- First company to implement Principal Component Analysis (PCA) in a commercial product for analysis of expression array data.
Our Products
BioDiscovery develops and markets a comprehensive line of bioinformatics products capable of integrating the entire microarray experimental process. ImaGene, and ImaGeneCGH are designed to function as standalone products or together as integrated software modules. In either mode they provide novel features and capabilities for automation of array processing, visualization and analysis.
In addition, BioDiscovery has developed a enterprise-wide software product called GeneDirector®, which combines the power and convenience of a database to manage large amounts of microarray data. GeneDirector integrates all the BioDiscovery software applications as well as data from sources such as Affymetrix GeneChip®. The Array Results Manager (ARM) extends GeneDirector functionality by allowing researchers to pose experimental questions in term of biological factors and avoids the need to have detailed information about the experimental process thereby facilitating discovery to a wide range of researchers.